{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:18:33Z","timestamp":1767651513161},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Predicting the chances mortality within 1\u00a0year in non-ischemic dilated cardiomyopathy patients can be very useful in clinical decision-making. This study has developed and validated a risk-prediction model for identifying factors contributing to mortality within 1\u00a0year in such patients. The predictive nomogram was constructed using a retrospective cohort study, with 615 of patients hospitalized in the First Affiliated Hospital of Guangxi Medical University between October 2012 and May 2020. A variety of factors, including presence of comorbidities, demographics, results of laboratory tests, echocardiography data, medication strategies, and instances of heart transplant or death were collected from electronic medical records and follow-up telephonic consultations. The least absolute shrinkage and selection operator and logistic regression analyses were used to identify the critical clinical factors for constructing the nomogram. Calibration, discrimination, and clinical usefulness of the predictive model were assessed using the calibration plot, C-index and decision curve analysis. Internal validation was assessed with bootstrapping validation. Among the patients from whom follow-up data were obtained, the incidence of an end event (deaths or heart transplantation within 1\u00a0year) was 171 cases per 1000 person-years (105 out of 615). The main predictors included in the nomogram were pulse pressure, red blood cell count, left ventricular end-diastolic dimension, levels of N-terminal pro b-type natriuretic peptide, medical history, in-hospital worsening heart failure, and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. The model showed excellent discrimination with a C-index of 0.839 (95% CI 0.799\u20130.879), and the calibration curve demonstrated good agreement. The C-index of internal validation was 0.826, which demonstrated that the model was quite efficacious. A decision curve analysis confirmed that our nomogram was clinically useful. In this study, we have developed a nomogram that can predict the risk of death within 1\u00a0year in patients with non-ischemic dilated cardiomyopathy. This will be useful in the early identification of patients in the terminal stages for better individualized clinical decisions.<\/jats:p>","DOI":"10.1038\/s41598-022-12249-7","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T10:04:24Z","timestamp":1653041064000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development and validation of a nomogram to predict the risk of death within 1\u00a0year in patients with non-ischemic dilated cardiomyopathy: a retrospective cohort study"],"prefix":"10.1038","volume":"12","author":[{"given":"Yuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Jian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"12249_CR1","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1093\/eurheartj\/ehv390","volume":"36","author":"S Hamshere","year":"2015","unstructured":"Hamshere, S. et al. Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: The REGENERATE-DCM clinical trial. Eur. Heart J. 36, 3061\u20133069. https:\/\/doi.org\/10.1093\/eurheartj\/ehv390 (2015).","journal-title":"Eur. Heart J."},{"key":"12249_CR2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","volume":"375","author":"JL Jefferies","year":"2010","unstructured":"Jefferies, J. L. & Towbin, J. A. Dilated cardiomyopathy. Lancet 375, 752\u2013762. https:\/\/doi.org\/10.1016\/S0140-6736(09)62023-7 (2010).","journal-title":"Lancet"},{"key":"12249_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/01.cir.80.3.564","volume":"80","author":"MB Codd","year":"1989","unstructured":"Codd, M. B., Sugrue, D. D., Gersh, B. J. & Melton, L. J. 3rd. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975\u20131984. Circulation 80, 564\u2013572. https:\/\/doi.org\/10.1161\/01.cir.80.3.564 (1989).","journal-title":"Circulation"},{"key":"12249_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cpcardiol.2012.07.003","volume":"38","author":"D Fairweather","year":"2013","unstructured":"Fairweather, D., Cooper, L. T. Jr. & Blauwet, L. A. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr. Probl. Cardiol. 38, 7\u201346. https:\/\/doi.org\/10.1016\/j.cpcardiol.2012.07.003 (2013).","journal-title":"Curr. Probl. Cardiol."},{"key":"12249_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ijcard.2016.06.167","volume":"220","author":"K Karatolios","year":"2016","unstructured":"Karatolios, K. et al. Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy. Int. J. Cardiol. 220, 608\u2013612. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.167 (2016).","journal-title":"Int. J. Cardiol."},{"key":"12249_CR6","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/ejhf.1216","volume":"20","author":"BP Halliday","year":"2018","unstructured":"Halliday, B. P. et al. Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy. Eur. J. Heart Fail. 20, 1392\u20131400. https:\/\/doi.org\/10.1002\/ejhf.1216 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"12249_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cjca.2019.05.031","volume":"36","author":"A Cannata","year":"2020","unstructured":"Cannata, A. et al. Sex differences in the long-term prognosis of dilated cardiomyopathy. Can. J. Cardiol. 36, 37\u201344. https:\/\/doi.org\/10.1016\/j.cjca.2019.05.031 (2020).","journal-title":"Can. J. Cardiol."},{"key":"12249_CR8","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/ehf2.12809","volume":"7","author":"E Dziewiecka","year":"2020","unstructured":"Dziewiecka, E. et al. Mortality risk in dilated cardiomyopathy: The accuracy of heart failure prognostic models and dilated cardiomyopathy-tailored prognostic model. ESC Heart Fail. 7, 2455\u20132467. https:\/\/doi.org\/10.1002\/ehf2.12809 (2020).","journal-title":"ESC Heart Fail."},{"key":"12249_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jcsm.12702","volume":"12","author":"M Konishi","year":"2021","unstructured":"Konishi, M. et al. Prognostic impact of muscle and fat mass in patients with heart failure. J. Cachexia Sarcopenia Muscle 12, 568\u2013576. https:\/\/doi.org\/10.1002\/jcsm.12702 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"12249_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms22115688","volume":"22","author":"L Anghel","year":"2021","unstructured":"Anghel, L., Sascau, R., Zota, I. M. & Statescu, C. Well-known and novel serum biomarkers for risk stratification of patients with non-ischemic dilated cardiomyopathy. Int. J. Mol. Sci. 22, 20. https:\/\/doi.org\/10.3390\/ijms22115688 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"12249_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","volume":"390","author":"RG Weintraub","year":"2017","unstructured":"Weintraub, R. G., Semsarian, C. & Macdonald, P. Dilated cardiomyopathy. Lancet 390, 400\u2013414. https:\/\/doi.org\/10.1016\/S0140-6736(16)31713-5 (2017).","journal-title":"Lancet"},{"key":"12249_CR12","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","volume":"67","author":"AG Japp","year":"2016","unstructured":"Japp, A. G., Gulati, A., Cook, S. A., Cowie, M. R. & Prasad, S. K. The diagnosis and evaluation of dilated cardiomyopathy. J. Am. Coll. Cardiol. 67, 2996\u20133010. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.590 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12249_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ejhf.1103","volume":"20","author":"M Merlo","year":"2018","unstructured":"Merlo, M. et al. Evolving concepts in dilated cardiomyopathy. Eur. J. Heart Fail. 20, 228\u2013239. https:\/\/doi.org\/10.1002\/ejhf.1103 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"12249_CR14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/ejhf.1914","volume":"22","author":"M Merlo","year":"2020","unstructured":"Merlo, M. et al. Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy. Eur. J. Heart Fail. 22, 1111\u20131121. https:\/\/doi.org\/10.1002\/ejhf.1914 (2020).","journal-title":"Eur. J. Heart Fail."},{"key":"12249_CR15","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1161\/CIR.0000000000000549","volume":"138","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib, S. M. et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 138, e272\u2013e391. https:\/\/doi.org\/10.1161\/CIR.0000000000000549 (2018).","journal-title":"Circulation"},{"key":"12249_CR16","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","volume":"34","author":"SJ Pocock","year":"2013","unstructured":"Pocock, S. J. et al. Predicting survival in heart failure: A risk score based on 39 372 patients from 30 studies. Eur. Heart J. 34, 1404\u20131413. https:\/\/doi.org\/10.1093\/eurheartj\/ehs337 (2013).","journal-title":"Eur. Heart J."},{"key":"12249_CR17","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy, W. C. et al. The Seattle heart failure model: Prediction of survival in heart failure. Circulation 113, 1424\u20131433. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.584102 (2006).","journal-title":"Circulation"},{"key":"12249_CR18","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","volume":"31","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J. Clin. Oncol. 31, 1188\u20131195. https:\/\/doi.org\/10.1200\/JCO.2012.41.5984 (2013).","journal-title":"J. Clin. Oncol."},{"key":"12249_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ebiom.2019.02.048","volume":"41","author":"H Zhong","year":"2019","unstructured":"Zhong, H. et al. Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin\u2019s lymphoma. EBioMedicine 41, 167\u2013174. https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.048 (2019).","journal-title":"EBioMedicine"},{"key":"12249_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.21037\/atm.2016.03.35","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. Variable selection with stepwise and best subset approaches. Ann. Transl. Med. 4, 136. https:\/\/doi.org\/10.21037\/atm.2016.03.35 (2016).","journal-title":"Ann. Transl. Med."},{"key":"12249_CR21","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jtcvs.2017.12.107","volume":"155","author":"SY Park","year":"2018","unstructured":"Park, S. Y. Nomogram: An analogue tool to deliver digital knowledge. J. Thorac. Cardiovasc. Surg. 155, 1793. https:\/\/doi.org\/10.1016\/j.jtcvs.2017.12.107 (2018).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"12249_CR22","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos, A., Schrag, D., Raj, G. V. & Panageas, K. S. How to build and interpret a nomogram for cancer prognosis. J. Clin. Oncol. 26, 1364\u20131370. https:\/\/doi.org\/10.1200\/JCO.2007.12.9791 (2008).","journal-title":"J. Clin. Oncol."},{"key":"12249_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCHEARTFAILURE.112.967828","volume":"6","author":"S Barlera","year":"2013","unstructured":"Barlera, S. et al. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell\u2019Infarto Miocardico-Heart Failure trial: Proposal for a nomogram. Circ. Heart Fail. 6, 31\u201339. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.967828 (2013).","journal-title":"Circ. Heart Fail."},{"key":"12249_CR24","doi-asserted-by":"publisher","first-page":"548","DOI":"10.12998\/wjcc.v7.i5.548","volume":"7","author":"M Rodriguez-Gonzalez","year":"2019","unstructured":"Rodriguez-Gonzalez, M., Sanchez-Codez, M. I., Lubian-Gutierrez, M. & Castellano-Martinez, A. Clinical presentation and early predictors for poor outcomes in pediatric myocarditis: A retrospective study. World J. Clin. Cases 7, 548\u2013561. https:\/\/doi.org\/10.12998\/wjcc.v7.i5.548 (2019).","journal-title":"World J. Clin. Cases"},{"key":"12249_CR25","doi-asserted-by":"publisher","first-page":"e014240","DOI":"10.1161\/JAHA.119.014240","volume":"8","author":"C Caraballo","year":"2019","unstructured":"Caraballo, C. et al. Clinical implications of the New York Heart Association Classification. J. Am. Heart Assoc. 8, e014240. https:\/\/doi.org\/10.1161\/JAHA.119.014240 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"12249_CR26","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.amjcard.2016.08.053","volume":"118","author":"SL den Boer","year":"2016","unstructured":"den Boer, S. L. et al. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements to predict cardiac death in acute and chronic dilated cardiomyopathy in children. Am. J. Cardiol. 118, 1723\u20131729. https:\/\/doi.org\/10.1016\/j.amjcard.2016.08.053 (2016).","journal-title":"Am. J. Cardiol."},{"key":"12249_CR27","doi-asserted-by":"publisher","first-page":"e001193","DOI":"10.1161\/JAHA.114.001193","volume":"3","author":"K Narayanan","year":"2014","unstructured":"Narayanan, K. et al. Left ventricular diameter and risk stratification for sudden cardiac death. J. Am. Heart Assoc. 3, e001193. https:\/\/doi.org\/10.1161\/JAHA.114.001193 (2014).","journal-title":"J. Am. Heart Assoc."},{"issue":"Suppl A","key":"12249_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/eurheartj\/4.suppl_a.173","volume":"4","author":"F Waagstein","year":"1983","unstructured":"Waagstein, F., Hjalmarson, A., Swedeberg, K. & Wallentin, I. Beta-blockers in dilated cardiomyopathies: They work. Eur. Heart J. 4(Suppl A), 173\u2013178. https:\/\/doi.org\/10.1093\/eurheartj\/4.suppl_a.173 (1983).","journal-title":"Eur. Heart J."},{"key":"12249_CR29","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/s0735-1097(02)02304-5","volume":"40","author":"AP Maggioni","year":"2002","unstructured":"Maggioni, A. P. et al. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. J. Am. Coll. Cardiol. 40, 1414\u20131421. https:\/\/doi.org\/10.1016\/s0735-1097(02)02304-5 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12249_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","volume":"35","author":"MR Mehra","year":"2016","unstructured":"Mehra, M. R. et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J. Heart Lung Transplant 35, 1\u201323. https:\/\/doi.org\/10.1016\/j.healun.2015.10.023 (2016).","journal-title":"J. Heart Lung Transplant"},{"key":"12249_CR31","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ijcard.2016.07.232","volume":"223","author":"G Sinagra","year":"2016","unstructured":"Sinagra, G. et al. Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy. Int. J. Cardiol. 223, 596\u2013603. https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.232 (2016).","journal-title":"Int. J. Cardiol."},{"key":"12249_CR32","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1097\/TP.0000000000001672","volume":"101","author":"CK Chen","year":"2017","unstructured":"Chen, C. K. et al. The utility of cardiopulmonary exercise testing for the prediction of outcomes in ambulatory children with dilated cardiomyopathy. Transplantation 101, 2455\u20132460. https:\/\/doi.org\/10.1097\/TP.0000000000001672 (2017).","journal-title":"Transplantation"},{"key":"12249_CR33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"Group C. T. S","year":"1987","unstructured":"Group C. T. S. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N. Engl. J. Med. 316, 1429\u20131435. https:\/\/doi.org\/10.1056\/NEJM198706043162301 (1987).","journal-title":"N. Engl. J. Med."},{"key":"12249_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-020-09940-0","author":"BO Cojan-Minzat","year":"2020","unstructured":"Cojan-Minzat, B. O., Zlibut, A. & Agoston-Coldea, L. Non-ischemic dilated cardiomyopathy and cardiac fibrosis. Heart Fail. Rev. https:\/\/doi.org\/10.1007\/s10741-020-09940-0 (2020).","journal-title":"Heart Fail. Rev."},{"key":"12249_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.13201\/j.issn.1001-1439.2018.05.001","volume":"34","author":"CMAC Branch","year":"2018","unstructured":"Branch, C. M. A. C., CMACC Group. Guidelines for the diagnosis and treatment of dilated cardiomyopathy in China. J. Clin. Cardiovasc. Dis. 34, 421\u2013434. https:\/\/doi.org\/10.13201\/j.issn.1001-1439.2018.05.001 (2018).","journal-title":"J. Clin. Cardiovasc. Dis."},{"key":"12249_CR36","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/ejhf.333","volume":"17","author":"J Butler","year":"2015","unstructured":"Butler, J. et al. In-hospital worsening heart failure. Eur. J. Heart Fail. 17, 1104\u20131113. https:\/\/doi.org\/10.1002\/ejhf.333 (2015).","journal-title":"Eur. J. Heart Fail."},{"key":"12249_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"12249_CR38","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1002\/sim.3148","volume":"26","author":"W Sauerbrei","year":"2007","unstructured":"Sauerbrei, W., Royston, P. & Binder, H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat. Med. 26, 5512\u20135528. https:\/\/doi.org\/10.1002\/sim.3148 (2007).","journal-title":"Stat. Med."},{"key":"12249_CR39","doi-asserted-by":"publisher","first-page":"e0201515","DOI":"10.1371\/journal.pone.0201515","volume":"13","author":"M Hu","year":"2018","unstructured":"Hu, M. et al. Development and validation of a risk-prediction nomogram for patients with ureteral calculi associated with urosepsis: A retrospective analysis. PLoS\u00a0One 13, e0201515. https:\/\/doi.org\/10.1371\/journal.pone.0201515 (2018).","journal-title":"PLoS\u00a0One"},{"key":"12249_CR40","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","volume":"35","author":"C O'Mahony","year":"2014","unstructured":"O\u2019Mahony, C. et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur. Heart J. 35, 2010\u20132020. https:\/\/doi.org\/10.1093\/eurheartj\/eht439 (2014).","journal-title":"Eur. Heart J."},{"key":"12249_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1472-6947-8-53","volume":"8","author":"AJ Vickers","year":"2008","unstructured":"Vickers, A. J., Cronin, A. M., Elkin, E. B. & Gonen, M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med. Inform. Decis. Mak. 8, 53. https:\/\/doi.org\/10.1186\/1472-6947-8-53 (2008).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"12249_CR42","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"YQ Huang","year":"2016","unstructured":"Huang, Y. Q. et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J. Clin. Oncol. 34, 2157\u20132164. https:\/\/doi.org\/10.1200\/JCO.2015.65.9128 (2016).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12249-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12249-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12249-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:21:09Z","timestamp":1669346469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12249-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12249"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12249-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"22 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8513"}}